Stay updated with breaking news from Thibaud portal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical candidate selection finalised for lead programme targeting mast-cell driven diseases Dermatology industry veteran Thibaud Portal, PhD appointed as CEO LONDON, March 30, 2023 ....
/PRNewswire/ Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating mast cell driven. ....
/PRNewswire/ Aldena Therapeutics Inc. (Aldena) a private biotech company pioneering siRNA-based therapies for dermatological indications, announces an. ....